+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
MALE
ID06772441

Personalized Radiotherapy with Androgen Deprivation Therapy for High-Risk Localized Prostate Cancer Using AI Classification

Led by German Oncology Center, Cyprus · Updated on 2026-09-15

30

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating a new way to personalize radiotherapy and androgen deprivation therapy ADT duration for men with high-risk localized prostate cancer. This single-arm, phase II study uses advanced artificial intelligence to classify patients and tailor treatment. The goal is to shorten ADT duration while maintaining effective disease control and potentially reducing side effects compared to current guidelines. Participants will receive a combination of treatments starting with a high-dose-rate brachytherapy HDR BT boost to the prostate, delivering 15 Gray in a single fraction. After a break of about two weeks, they will undergo stereotactic body radiation therapy SBRT delivering 25 Gray in five daily fractions to the prostate and seminal vesicles. Alongside radiation, patients will take androgen deprivation therapy for 12 months, given concurrently and as an adjuvant. During the study, participants will have regular assessments including imaging scans, biopsies, and quality of life questionnaires. Researchers will monitor disease-free survival at five years as the primary outcome, along with secondary measures such as local or regional failure, metastatic-free survival, overall survival, prostate cancer-specific survival, biochemical failure, and treatment-related toxicities. Testosterone recovery and quality of life will also be evaluated up to five years after treatment completion.

CONDITIONS

Brief Title

Artificial Intelligence Driven Personalisation of Radiotherapy and Concomitant Androgen Deprivation Therapy for Prostate Cancer Patients (the HypoPro Trial)

Research Team

E

Elena Pallari, PhD

K

Kristis Vevis, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here